Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study.
- DOI
- 10.1016/j.lungcan.2026.109621
- Published
- 2026 Sep 5
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109621,
title = {Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study.},
author = {Eijkelboom AH and Peters BJM and Dumoulin DW and Schramel FMNH and Damhuis RAM and van Geffen WH},
year = {2026},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2026.109621},
url = {https://doi.org/10.1016/j.lungcan.2026.109621}
}RIS
TY - JOUR TI - Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study. AU - Eijkelboom AH AU - Peters BJM AU - Dumoulin DW AU - Schramel FMNH AU - Damhuis RAM AU - van Geffen WH PY - 2026 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2026.109621 UR - https://doi.org/10.1016/j.lungcan.2026.109621 ER -
APA
AH, E., BJM, P., DW, D., FMNH, S., RAM, D., & WH, V. G. (2026). Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2026.109621
Source records
- pubmed · retrieved 2026-09-26T04:23:06.748Z